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Abstract
Background: Smoking in pregnancy is a major public health concern. Pregnant smokers are particularly difficult to reach, with
low uptake of support options and few effective interventions. Text message–based self-help is a promising, low-cost intervention
for this population, but its real-world uptake is largely unknown.
Objective: The objective of this study was to explore the uptake and cost-effectiveness of a tailored, theory-guided, text message
intervention for pregnant smokers (“MiQuit”) when advertised on the internet.
Methods: Links to a website providing MiQuit initiation information (texting a short code) were advertised on a cost-per-click
basis on 2 websites (Google Search and Facebook; £1000 budget each) and free of charge within smoking-in-pregnancy webpages
on 2 noncommercial websites (National Childbirth Trust and NHS Choices). Daily budgets were capped to allow the Google and
Facebook adverts to run for 1 and 3 months, respectively. We recorded the number of times adverts were shown and clicked on,
the number of MiQuit initiations, the characteristics of those initiating MiQuit, and whether support was discontinued prematurely.
For the commercial adverts, we calculated the cost per initiation and, using quit rates obtained from an earlier clinical trial,
estimated the cost per additional quitter.
Results: With equal capped budgets, there were 812 and 1889 advert clicks to the MiQuit website from Google (search-based)
and Facebook (banner) adverts, respectively. MiQuit was initiated by 5.2% (42/812) of those clicking via Google (95% CI
3.9%-6.9%) and 2.22% (42/1889) of those clicking via Facebook (95% CI 1.65%-2.99%). Adverts on noncommercial webpages
generated 53 clicks over 6 months, with 9 initiations (9/53, 17%; 95% CI 9%-30%). For the commercial websites combined,
mean cost per initiation was £24.73; estimated cost per additional quitter, including text delivery costs, was £735.86 (95% CI
£227.66-£5223.93). Those initiating MiQuit via Google were typically very early in pregnancy (median gestation 5 weeks,
interquartile range 10 weeks); those initiating via Facebook were distributed more evenly across pregnancy (median gestation 16
weeks, interquartile range 14 weeks).
Conclusions: Commercial online adverts are a feasible, likely cost-effective method for engaging pregnant smokers in digital
cessation support and may generate uptake at a faster rate than noncommercial websites. As a strategy for implementing MiQuit,
online advertising has large reach potential and can offer support to a hard-to-reach population of smokers.
(J Med Internet Res 2018;20(4):e146)   doi:10.2196/jmir.8525
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Introduction
Background
In developed countries, smoking during pregnancy is a leading
preventable cause of adverse prenatal outcomes, including
miscarriage [1], stillbirth [2,3], and prematurity [4]. It is also
associated with a wide range of infant health problems [5]. In
the United Kingdom, around 11% of women are estimated to
smoke throughout pregnancy [6], but rates rise considerably
with increasing social deprivation [6,7], standing at around 5
times higher in the most deprived women than in the least [7].
Children born to smokers are also more likely to become
smokers themselves [8]. Thus, smoking in pregnancy not only
puts great financial burden on health services but also
perpetuates and exacerbates health inequalities. Reducing its
prevalence is a public health priority [9].
Most pregnant smokers want to quit [10], and effective
interventions exist to help them [11,12]. Specialist Stop Smoking
Services in England offer free pregnancy cessation support with
proven efficacy [12]; however, uptake is low [13], with
convenience and concerns about being judged reported as
barriers to access [14]. In addition to addressing these barriers,
research efforts have also been focused on developing effective
and cost-effective “distance” alternatives that will appeal to
pregnant smokers and be used sufficiently to yield a public
health benefit. Self-help cessation support appeals to pregnant
smokers [15], and delivering self-help by mobile phone text
messaging may be helpful for this group, given its low cost,
convenience, anonymity, and wide reach potential, with mobile
phone ownership high across the socioeconomic spectrum [16].
Systematic review evidence shows that self-help cessation
interventions for pregnant smokers can be effective [17] and
that mobile phone–based cessation interventions are effective
for nonpregnant smokers [18].
MiQuit Intervention for Pregnant Smokers
We have developed a low-cost, tailored, text-messaging
intervention specifically for pregnant smokers (“MiQuit”) [19].
MiQuit is feasible to deliver and highly acceptable to pregnant
smokers [19], and a recent randomized controlled trial (RCT;
n=407) found that offering MiQuit in addition to usual care
shows promising efficacy and cost-effectiveness [20]. As MiQuit
is fully automated and user-initiated, women can start using it
without the need for any health professional involvement, thus
minimizing potential implementation costs. However, little is
currently known about the likely real-world uptake of MiQuit
should this become routinely available to pregnant smokers, or
what the best implementation strategies might be to maximize
its reach and initiate users into support as cost-effectively as
possible. The public health impact of an intervention depends
crucially on its real-world uptake, as well as its efficacy, but
evaluations of smoking cessation interventions have largely
neglected to estimate this [21].
Using the Internet to Offer Cessation Support
The internet has obvious potential as a tool for reaching pregnant
smokers and enrolling them into cessation programs, and
evidence suggests that a digital intervention may particularly
appeal to smokers offered cessation support through digital
media [22]. Interventions can be promoted to potential users on
the internet through commercial search-engine and banner-based
(pop-up) adverts, as well as noncommercial websites. A previous
real-world study in an antenatal setting estimated that 3% to
4% of pregnant smokers initiated MiQuit after a brief
promotional leaflet was placed into their maternity booking
pack without any introduction or endorsement from a health
professional [23]. If pregnant women will initiate MiQuit after
reading a brief leaflet, it seems likely that they may do so after
reading an online advert. Offering MiQuit to pregnant smokers
through search engines, in particular, might reach them earlier
in pregnancy than they would typically be targeted in antenatal
settings, thus maximizing the benefits of quitting to the fetus.
Search-based adverts could also present an opportunity to offer
support to women when they are motivated to quit, with cohort
evidence suggesting that repeated quit attempts may be made
throughout pregnancy [24]. As a tool for recruiting smokers
into research trials of digital interventions, studies of
nonpregnant groups [25-30] suggest that commercial online
advertising can achieve high participant yield rapidly [26,27]
and can recruit traditionally hard-to-reach smoker populations
at relatively low cost [29,30]. However, although studies
typically show similar participant characteristics and retention
rates for smokers recruited through online versus traditional
means [26-28], with the notable exception of younger age in
those recruited via social media [27], others have found lower
quitting confidence and lower study completion rates among
smokers recruited to trials via the internet [31].
We are aware of only 2 previous studies to explore real-world
uptake of digital smoking cessation support, rather than
recruitment rates to cessation trials, as a consequence of online
advertising, both of which targeted nonpregnant smokers
[32,33]. To our knowledge, no published studies have explored
uptake of cessation support among pregnant smokers via the
internet. In addition, we know little about the characteristics of
pregnant smokers who can be encouraged to take up digital
interventions over the internet. In this study, therefore, we
investigate whether pregnant smokers will initiate the MiQuit
intervention after seeing paid-for or free online advertising; in
addition, we monitor the costs incurred and, using a previously
obtained estimate for MiQuit efficacy [20], assess the extent to
which commercial online advertising might be cost-effective.
Finally, we document the extent to which users engage with the
support program, including the discontinuation rate, and describe
key characteristics, exploring differences between pregnant
smokers initiating MiQuit via different online routes.
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Methods
Design
This was an evaluation of the uptake of a digital
(text-messaging) intervention advertised on the internet. Uptake
rates of MiQuit were monitored while it was advertised via 4
concurrent online settings: 2 commercial websites and 2
noncommercial webpage links.
MiQuit Cessation Support for Pregnant Smokers
MiQuit provides a 12-week program of automated,
theory-guided, interactive support for quitting smoking in
pregnancy, delivered by text message. Support is tailored to 12
baseline user characteristics plus name, gestation, and smoking
status, the latter collected at 3 and 7 weeks by text message.
Tailoring characteristics include nicotine dependence, partner’s
smoking status, and confidence, motivation, and determination
to quit [19,20,23]. Women initiate MiQuit by texting a short
code number. They are then invited to complete 12 baseline
tailoring questions, including the option of setting a quit date,
either by text or by website. Those tailoring by website must
answer all other 11 questions. Those tailoring by text are given
the option of answering either 6 or 12 tailoring questions but
can stop responding at any point. If no tailoring questions are
answered using either route, then generic support is delivered.
MiQuit delivers 0-2 scheduled daily texts (“push” support),
including motivational messages; advice about quit attempt
preparation, managing cravings, or trigger situations; and
information about fetal development and how smoking affects
it. Those setting a quit date receive extra support oriented around
their nominated date. Users can access on-demand, “pull”
support for combatting cravings (“HELP”), returning to
abstinence after a lapse (“SLIP”), or for distraction (“QUIZ”).
The support lasts for 12 weeks unless discontinued prematurely
by the user sending a “STOP” message. MiQuit texts are free
to receive. Sending the initiation text and any subsequent texts
sent by the user are either free or cost the user’s standard text
message rate, depending on their phone “bundle.”
Web-Based Advertising Campaign
Overview of Advertising Methods
With the aim of reaching as many pregnant smokers as possible,
we chose 2 commercial advertisers with very large reach
potential: Google AdWords [34] (search-based) and Facebook
Ads [35] (banner). To identify UK websites most likely to
appear as a result of internet searches for smoking-in-pregnancy
keywords, 2 search engines (Google and Bing) were used to
identify the top webpages returned for the phrase “quit smoking
in pregnancy” and close variants. The National Health Service
(NHS) website (“NHS Choices”) and the National Childbirth
Trust (NCT) website, whose “smoking in pregnancy” webpages
[36,37] were consistently close to the top of the search results,
agreed to place free-of-charge, text-only links to MiQuit on
these webpages.
Advert Content
Key points made in the adverts were that MiQuit is smoking
cessation support by text message; MiQuit is for pregnant
smokers; MiQuit is NHS supported; and MiQuit is free to
receive. Separate adverts were created for each of the 4 online
settings, with input from a Patient and Public Involvement
representative, keeping the text as similar as possible between
adverts given their character or space limits (Multimedia
Appendix 1).
MiQuit Sign-Up Website
Clicking on any of the 4 adverts led directly to a MiQuit sign-up
website that provided further information about MiQuit and
how to initiate it. Each advert led to a separate website clone
with a different short code number, enabling us to isolate traffic
and initiations from each source. Those wanting to initiate
MiQuit had to navigate to the “sign-up” page, click on the
“sign-up” button, and submit a response to a question asking
where they first heard about MiQuit (“submissions”). The latter
acted as a check that women had not reached the website through
other means than our online adverts, such as through the
recommendation of a health professional. They were then
presented with the short code number on a webpage, with
instructions to text the word “QUIT” to the number to begin
support. The 4 short codes were not promoted anywhere outside
of the 4 cloned websites. To ensure that the websites would not
appear in the results of search engines, we added the “disallow”
command on the websites’ robots.txt file, which requests Web
robots not to scan the websites. This was checked periodically
to ensure the most commonly used search engines complied
with this request.
Commercial Advert Settings
Google AdWords displays a brief, 3-line, text-only advert when
advertiser-specified keywords are typed into Google Search.
Facebook Ads display a text and image banner advert,
unsolicited, to a specified demographic (eg, by age, gender,
location, and interests), potentially multiple times per person.
We added an image of a pregnant smoker, used elsewhere for
promoting MiQuit [23], to the text for the Facebook advert.
Detailed descriptions of Google and Facebook advertising can
be found elsewhere [29,30] but, with both, costs depend on
competition from other advertisers. We used a cost-per-click
option for both adverts. As we could find no similar studies
among pregnant smokers to inform how expenditure would
translate into initiations, we set a capped budget of £1000 for
each. We restricted both adverts to the United Kingdom, but
put no time of day or day of week limits on their scheduling.
Google keyword phrases specified were “smoking in
pregnancy,” “stop smoking in pregnancy,” “dangers of smoking
in pregnancy,” and close variants. Estimated search traffic was
relatively low for these; so, broad-match keywords, which permit
any combination of the words comprising the phrase, were added
to widen reach. On the basis of estimated search traffic and click
costs for our keywords (provided by Google), we set a daily
budget of £33 for the Google advert, hence a campaign duration
of 1 month. For Facebook, we restricted our advert to females
aged 16-45 years and specified “pregnancy” and “childbirth”
as interests. On the basis of the estimated click costs for our
target audience (provided by Facebook), we set a daily budget
of £10 for the Facebook advert, hence a campaign duration of
3 months.
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Free Links
A brief, text-only advert was displayed, permanently for 6
months, on both the NCT and NHS Choices webpage on
smoking in pregnancy, under an “external links” section. These
had low screen visibility compared with the 2 commercial
adverts.
Procedure
The 4 adverts were run concurrently, beginning late May 2015,
either until their budget ended (commercial adverts) or for 6
months (free links). Initiations were permitted up to 3 months
after each advert ceased to be shown. The 2 commercial adverts
were monitored closely throughout the campaigns. The
performance metrics these supply (shown below) were compiled
on a weekly basis. Numbers of MiQuit submissions, initiations,
and discontinuations were compiled weekly for all 4 sources.
Measures and Analyses
Advert Performance and Uptake of MiQuit
The 2 commercial advertisers supplied a variety of reach and
cost metrics (Textbox 1). The 2 noncommercial websites, NHS
Choices and NCT, each provided the number of unique visits
to their smoking in pregnancy webpage, where our advert was
located. We used Google Analytics on the landing webpages
of the MiQuit sign-up website for these noncommercial adverts
to determine the number of clicks they received.
For all 4 cloned MiQuit websites, the MiQuit server recorded
the number of times the initiation short code was accessed
(submissions), whether submissions were from a desktop or
mobile phone, and the number of MiQuit initiations. As in
similar online uptake studies among nonpregnant smokers
[32,33], uptake rate was calculated as the percentage of MiQuit
initiations out of the total number of clicks on an advert to the
MiQuit sign-up website. Data are presented as frequencies and
percentages, with 95% Wilson CIs. For the commercial adverts,
we also estimated the number of initiations per individual
reached and calculated the cost per initiation. For the purposes
of analyses, it was assumed that each advert click, submission,
and initiation represented one individual, and that each Google
advert impression represented one individual reached. Facebook
provided the number of individuals reached by the advert
(“people served”), given that an individual can be targeted
repeatedly.
Estimated Cost-Effectiveness
We estimated the likely incremental cost per additional quitter
(also known as the “Incremental Cost-Effectiveness Ratio”) of
both initiating women into MiQuit via commercial online
advertising and delivering the support by summing the mean
commercial advert cost and mean cost of sending the texts in
this study (£0.035 per text at time of study), divided by the
incremental quit rate found in a recent RCT of the MiQuit
intervention (3.46%) [20]. In this RCT, pregnant smokers
(n=407) were recruited from 16 antenatal clinics in England via
face-to-face contact and, after responding to tailoring questions
by telephone to a researcher, were randomized to receive either
MiQuit added to usual NHS smoking cessation care or usual
care alone. The quit rate for prolonged, biochemically-validated
abstinence in the MiQuit group was 5.42% (1.96% for usual
care) and the odds ratio, adjusted for site and gestation, was
2.70 (95% CI 0.93-9.35) for MiQuit over usual care [20]. This
is the best estimate yet produced for the likely efficacy of
MiQuit, although it has limited precision. To determine the
impact of uncertainty, we bootstrapped 1000 times our
incremental quit rate and cost to estimate the 95% CIs for the
cost per additional quitter [38]. In addition, there was a fixed
annual running cost, shared across all users, of approximately
£760, consisting of a virtual reply number (£99), Web hosting
with domain name (£240), and short code (£420). This was not
included in the cost-effectiveness analysis as a per-person cost
could not be calculated: the annual number of users is currently
an unknown quantity.
User Engagement and Characteristics
MiQuit server data were used to assess engagement with the
support program, including rates of tailoring question
completion, quit date setting, use of “pull-support” features,
and discontinuations (sending a “STOP” message). Data are
presented as frequencies and percentages, with 95% Wilson CIs
presented for key measures (discontinuation rate and quit date
setting). Key behavioral characteristics of those initiating MiQuit
were taken from their responses to the tailoring questions,
answered by Web or text. Characteristics were compared
between those initiating MiQuit via different online sources,
where numbers permitted, using Mann-Whitney U tests
(continuous data) and Fisher exact tests (categorical data).
Textbox 1. Advert reach and cost metrics supplied by the 2 commercial advertisers.
• Impressions—number of times the advert was displayed.
• People served (Facebook only)—number of individuals the advert was displayed to.
• Impression share (Google only)—proportion of times the advert was displayed when a relevant keyword search was made. This shows the number
of impressions achievable given an unlimited budget.
• Clicks—number of times the advert was clicked on. A click took the user directly to the MiQuit sign-up website, so the number of clicks equates
to the number of website visits.
• Cost per click—mean cost incurred for a single advert click.
• Proportion of impressions and clicks by device type (desktop or mobile).
• Mean screen position (Google only)—mean location of advert impressions on the Google search results page (1=top of screen).
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Ethical Approval
Advice was sought from the National Research Ethics Central
Queries Service as to whether the study should be classed as
research requiring ethical review, and they confirmed that no
ethical review was required. The study was conducted in
accordance with the ethical principles that have their origin in
the Declaration of Helsinki, 1996; the Principles of Good
Clinical Practice; and the Department of Health Research
Governance Framework for Health and Social Care, 2005.
Participants were able to withdraw from the MiQuit support at
any time.
Results
Advert Performance and Uptake of MiQuit
Most commercial advert clicks came from mobile devices rather
than desktops (Google: 560/812, 69.0%; Facebook: 1883/1889,
99.68%). Of those who accessed the initiation short code, 94.1%
(301/320) did so from a mobile device (Google: 110/121, 90.9%;
Facebook: 184/187, 98.4%; NHS Choices: 1/4, 25%; NCT: 6/8,
75%).
Figure 1 shows the flow of the targeted populations, through
each online route, into initiation of MiQuit support. The Google
advert was shown 29,022 times in its 1-month duration. Given
our impression share of 70% for mobile-based searches and
50% for desktop-based searches, we estimated that over 46,000
Google searches had been made for our keywords, in the United
Kingdom, during this time. The mean position of the Google
advert from the top of the screen was 1.0 for mobiles and 1.2
for desktops (highly visible). The Facebook advert was shown
to 248,618 broadly targeted women during its 3-month duration
(mean 2.4 times each) and also had high visibility on screen
(Multimedia Appendix 1). In 6 months, approximately 40,000
unique visits were made to the NHS Choices and NCT
smoking-in-pregnancy webpages containing the MiQuit link,
but the proportions who scrolled down to where the links were
placed on these is unknown.
In total, 2754 individuals clicked on 1 of the 4 adverts to the
MiQuit sign-up website (Google n=812, Facebook n=1889,
NHS Choices n=33, NCT n=20). For Google, assuming 1 advert
impression per person, this amounted to 2.80% of those served
the advert (812/29,022) and, for Facebook, 0.76% of those
served the advert (1889/248,618). For the NHS Choices and
NCT websites, the numbers of clicks on the MiQuit links
amounted to 0.09% (33/38,352) and 1.43% (20/1402),
respectively, of the numbers of unique visits to the webpages
containing the link.
MiQuit was initiated by 93 individuals in total, with the 2
commercial campaigns each yielding 42 initiations and the free
links 9 in total. For our uptake rate calculation, the percentage
who subsequently initiated MiQuit after clicking on an advert
to the MiQuit website was 3.38% (93/2754, 95% CI
2.76%-4.12%); Google 5.2% (42/812, 95% CI 3.9%-6.9%),
Facebook 2.22% (42/1889, 95% CI 1.65%-2.99%); NHS
Choices 9% (3/33; 95% CI 3%-24%), NCT 30% (6/20; 95% CI
15%-52%). One in 691 Google advert impressions resulted in
a MiQuit initiation (1 in 5919 women targeted by Facebook).
One in 12,784 visits to the NHS Choices webpage, and 1 in 234
visits to the NCT webpage, resulted in an initiation.
Commercial Advertising Costs and Estimated
Cost-Effectiveness
The Facebook campaign cost £1000, whereas the Google
campaign cost £1077, including £75 credited free to our account.
Table 1 shows a breakdown of these costs in terms of how far
MiQuit was accessed or activated. The mean cost per advert
click to the MiQuit website was £1.33 for the Google advert
and £0.53 for the Facebook advert. Both campaigns yielded
equal initiations for their budget. Cost per MiQuit initiation was
£25.64 via Google, £23.81 via Facebook, and £24.73 across
both campaigns. Table 1 also shows the estimated cost per
additional quitter of initiating pregnant smokers into MiQuit
via commercial online advertising. Using the cost per initiation
of the commercial adverts (£24.73) plus the mean cost of
sending the MiQuit texts to those initiating support here (£2.73)
gave a point estimate of £793.64 per additional quitter to both
initiate and deliver the support. The mean cost per additional
quitter from the bootstrap was £735.86 (95% CI
£227.66-£5223.93).
Engagement and Disengagement With MiQuit
A total of 53 of the 93 initiators in this study (57%, 95% CI
47%-67%) set at least 1 quit date with MiQuit during the
program, including at baseline. Moreover, 63 (68%) of the
initiators chose to answer all 12 tailoring questions by website
(with quit date noncompulsory). Of those who chose to answer
by text message instead (n=27), 16 (59%) responded to at least
the first 6 questions. Only 3 initiators (3%) answered no tailoring
questions and received generic support. “Pull” support features
(“HELP,” “SLIP,” and “QUIZ” requests) were used by 35 (38%)
initiators.
A total of 34 of the 93 initiators in this study (37%, 95% CI
27%-47%) stopped the 86-day program prematurely (mean days
into program 18.6, SD 21.3). Although not formally tested,
discontinuation rates, tailoring question completion rates, and
use of interactive program features did not appear to differ
between those taking up MiQuit via the 4 different online routes.
Characteristics of Those Initiating MiQuit
Table 2 shows key characteristics of those who initiated MiQuit
via online advertising (n=93) and statistically compares those
who initiated MiQuit via Google versus Facebook; numbers
were insufficient to compare data from the 2 free links (shown
combined). Readiness to quit smoking appeared high among
initiators in this study, with 70 out of 93 (78%) seriously
planning to quit within the next 2 weeks. Gestation differed
substantially between women who initiated support via Google
versus Facebook; no other characteristic differed significantly
between them. Those from Google were typically very early in
pregnancy, with 49% reporting a baseline gestation of 4 or 5
weeks (median 5 weeks; interquartile range [IQR] 10); those
from Facebook were distributed more widely across pregnancy
(median 16 weeks, IQR 14, Mann-Whitney U test P<.001).
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Figure 1. Flow diagram: MiQuit advert reach and initiation of support.
Table 1. Costs and estimated cost-effectiveness of the commercial online adverts.
Estimated cost per additional quitteraCost per:Advertising campaign
MiQuit initiationShort code obtained
Advert click, leading to the
MiQuit website
£741.04£25.64 (n=42)£8.90 (n=121)£1.33 (n=812)Google AdWords (spend £1077)b
£688.15£23.81 (n=42)£5.35 (n=187)£0.53 (n=1889)Facebook Ads (spend £1000)
£714.74£24.73 (n=84)£6.74 (n=308)£0.77 (n=2701)Both campaigns (spend £2077)b
aOn the basis of an incremental quit rate of 3.46% in the MiQuit randomized controlled trial (RCT) [20] (prolonged, validated abstinence).
bIncluding £75 credited free to our account by Google as a welcome offer.
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Table 2. Baseline characteristics of pregnant smokers initiating MiQuit via online advertising.
P valuebFree links (total)a (n=9)Facebook Ads (n=42)Google AdWords (n=42)Total (n=93)Baseline characteristic
<.001  Gestation (weeks)
7.1 (4.1)16.7 (8.5)9.1 (7.2)12.3 (8.5)Mean (SD)
6 (4, 8)16 (10, 24)5 (4, 14)9.5 (5, 18)Median (1st Q, 3rd Q)
4, 174, 322, 282, 32Min, max
9 (100)40 (95.2)41 (97.6)90 (96.8)Valid n (%)
.30  Are you seriously planning to quit? n (%)
7 (78)28 (72)35 (83)70 (78)Within the next 2 weeks
2 (22)7 (18)6 (14)15 (17)Within the next 30 days
0 (0)3 (8)0 (0)3 (3)Within the next 3 months
0 (0)1 (2)1 (2)2 (2)No
9 (100)39 (93)42 (100)90 (97)Valid n (%)
.36Confidence to quit for remainder of pregnancy, n (%)
2 (25)13 (35)6 (17)21 (26)Not at all
3 (38)7 (19)8 (23)18 (23)A little
2 (25)12 (32)15 (43)29 (36)Moderately
1 (13)4 (11)6 (17)11 (14)Very much
0 (0)1 (3)0 (0)1 (1)Extremely
8 (89)37 (88)35 (83)80 (86)Valid n (%)
.33  Cigarettes per day now, n (%)
0 (0)1 (3)5 (14)6 (8)1-3
1 (13)9 (25)6 (17)16 (20)4-5
2 (25)12 (33)9 (26)23 (29)6-10
2 (25)8 (22)9 (26)19 (24)11-15
2 (25)6 (17)4 (11)12 (15)16-20
1 (13)0 (0)2 (6)3 (4)21+
8 (89)36 (86)35 (83)79 (85)Valid n (%)
.24Heaviness of Smoking Indexc , n (%)
1 (13)12 (33)6 (17)19 (24)Very low
3 (38)12 (33)18 (51)33 (42)Low to moderate
3 (38)12 (33)9 (26)24 (30)Moderate
1 (13)0 (0)2 (6)3 (4)High
8 (89)36 (86)35 (83)79 (85)Valid n (%)
.30  Partner’s smoking status, n (%)
5 (63)22 (69)16 (53)43 (61)Smoker
3 (38)10 (31)14 (47)27 (39)Nonsmoker or no partner
8 (89)32 (76)30 (71)70 (75)Valid n (%)
aData for NCT (n=6) and NHS Choices (n=3) were combined because of small numbers.
bFacebook vs Google P value. Tested via Mann-Whitney U (continuous) or Fisher Exact test (frequencies).
cHeaviness of Smoking Index was based on the sum of scores from 2 items of the Fagerström Test of Cigarette Dependence [39]: cigarettes per day
(1-10=score of 0, 11-20=1, 21-30=2, >30=3) and time to first cigarette after waking (>1 hour=0, 31-60 min=1, 6-30 min=2, within 5 min=3). A combined
score of 0-2=very low dependence, 3=low to moderate dependence, 4=moderate dependence, and 5-6=high dependence.
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Discussion
Principal Findings
When a low-cost, text messaging, pregnancy smoking cessation
support program (MiQuit) was advertised via the internet, with
no other form of promotion or recommendation, an overall
uptake (initiation) rate of 3.4% was seen among those who
clicked on any of the 4 adverts to the MiQuit website.
Commercial adverts, which yielded the vast majority of
initiations in this study, cost, on average, £24.73 per initiation.
Although the initiation rate was higher among those who reached
the MiQuit website via free webpage links, the total number of
initiations generated through these was much lower than the
number of initiations generated by commercial advertising and
occurred over a longer time frame. Behavioral characteristics
appeared similar for those initiating MiQuit from different online
sources. User engagement appeared high as over half of initiators
set a quit date with the system, and approximately two-thirds
continued with MiQuit until the end of the 12-week program.
Strengths and Limitations
To our knowledge, this is the first study to explore the feasibility
of using free and paid-for online advertising to reach pregnant
smokers and promote their uptake of cessation support. We
have shown that a significant minority of pregnant smokers are
willing to initiate an automated text messaging intervention
when offered this via the internet; given the high reach of the
internet, this could translate into substantial numbers of pregnant
smokers supported to quit. Unlike many previous evaluations
of online advertising [25], we were able to trace the source of
all those who arrived at the MiQuit website and all who initiated
support, allowing us to compare uptake rates for different online
strategies. By quantifying each step of the uptake process, from
viewing an advert through to initiating support, we have
explored a spectrum of engagement [40] with the offer of
support and identified steps where barriers to uptake might be
removed. Importantly, we tracked individuals’ behavior beyond
support initiation, investigating their engagement with the
program (quit date setting, use of “pull” support messages,
tailoring question completion) as well as discontinuations
(sending a “STOP” message). We were also able to use previous
RCT data, with assumptions, to estimate the likely
cost-effectiveness of MiQuit if implemented via commercial
online adverts.
There are several limitations to this study, including some
general challenges for real-world uptake studies. As with many
studies recruiting people to interventions without person
involvement, we cannot be sure that those who took up support
were the intended group (ie, pregnant smokers), although our
adverts and website made it clear that MiQuit is for pregnant
smokers and almost all provided their gestation. It is also
possible that adverts were clicked on out of curiosity by those
who were neither pregnant nor smoking, particularly among
women targeted by banner adverts on Facebook, or that adverts
were passed on to others (eg, friends) by those originally
targeted. In addition, it proved difficult to estimate the numbers
of pregnant smokers exposed to each advert as a denominator:
the number of pregnant smokers shown our Facebook advert is
unknown and it is probable that not all Google searches for our
keywords were made by pregnant smokers. Nonetheless, the
high number of keyword searches made within the United
Kingdom in a month (over 46,000) suggests that there may be
many opportunities for engaging with this population on the
internet. Given the low visibility of the 2 free links, our use of
the number of visits to the webpages on which these were placed
as a denominator may have greatly underestimated the
proportions initiating MiQuit out of those exposed. Difficulties
in specifying accurate and comparable denominators have been
noted previously in uptake studies [23,41]. However, to health
providers, having accurate information on the numbers of
MiQuit initiations and on the cost of providing this is of the
greatest importance.
It is important to be aware of assumptions inherent to the
cost-effectiveness estimates presented. Our cost-effectiveness
analyses assumed that, when initiated via the internet, MiQuit
would have a similar quit rate to that observed in women
recruited to an RCT from antenatal clinics. However, we found
differences in characteristics between women in this study and
those recruited to the RCT (discussed below), and it is possible
that the intervention could vary in effectiveness for different
groups of women. Both Facebook and Google had relatively
opaque criteria used to determine their advertising charges; there
is no guarantee that similar charges would be made for identical
adverts in the future. Charges depend on concurrent competition
from other advertisers, so are unlikely to replicate exactly from
one campaign to another even if all other parameters are held
constant. It is probably best to view our cost-effectiveness
estimates as indicative rather than definitive; however,
optimization of this type of “programmatic” advertising would
likely reduce costs significantly.
Findings in Context
Compared with pregnant smokers who were recruited to a large
RCT of MiQuit via antenatal clinics in a previous study [20],
women who initiated MiQuit via online advertising in this study
had higher readiness to quit, with 78% (vs 32% RCT) seriously
planning to quit within the next 2 weeks and 57% (vs 19% RCT)
sending a quit date to MiQuit during the program, including at
baseline. This suggests that online initiators may be more likely
to make a quit attempt [42,43]. Conversely, online initiators
appeared to be more nicotine-dependent than RCT recruits, with
34% (vs 14% RCT) classed as “moderate” or “high”
dependence, and this appears to be a key determinant of failure
to quit during pregnancy [43-46]. It is, therefore, possible that
quit rates might be lower among individuals who engage with
MiQuit via the internet compared with those who did so after
being recruited to a trial in an NHS setting, but this is currently
speculative. Others have not found heavier smoking among
online recruits [31].This is an important avenue for future
evaluation: MiQuit could have different effects depending on
how it is implemented and, therefore, who makes use of it.
Previous research has found high readiness to quit in smokers
recruited to RCTs by search-based [29], but not banner, online
advertising methods [28]; however, in this study, readiness to
quit was similar between those initiating MiQuit via Google
and Facebook.
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A total of 37% of initiators in this study stopped the 12-week
program prematurely (sent a “STOP” message). This was
notably higher than the discontinuation rate among trial
participants, where 13% randomized to the MiQuit condition
discontinued the support [20], though more similar to the
discontinuation rate when MiQuit was offered in an NHS
real-world context, by leaflet (46%) [23]. It is possible that those
receiving MiQuit as part of an RCT felt obliged to continue with
it because of being a trial participant and receiving human
contact as part of their involvement. Previous MiQuit research
highlights that discontinuations are made for a variety of reasons,
most of which are not related to irritation or dissatisfaction [19],
and a separate study indicates that discontinuation can be an
indicator of increased engagement in smoking cessation behavior
[47]. In other ways, online initiators appeared more engaged
with MiQuit than RCT participants, with 3 times as many
sending a quit date to the system and almost twice as many
(38% vs 21%) sending a “pull” support message.
Although our Facebook advert generated activations throughout
pregnancy, those who initiated MiQuit via Google were often
early in gestation (around 50% within their first 5 weeks).
Adverts attached to internet search engines may, therefore, be
a useful way to reach women when they are first pregnant and
looking for support, and could potentially maximize health
benefits by encouraging abstinence for more of their pregnancy.
Currently, the earliest used cessation interventions tend to target
pregnant smokers at their antenatal booking appointment, at
around 8-12 weeks’ gestation.
We have shown that uptake of MiQuit via online advertising is
feasible; our previous real-world study showed uptake of MiQuit
to be feasible when offered via leaflets in maternity booking
packs without health professional promotion. This suggests that
there are promising routes to initiating pregnant smokers into
support systems such as MiQuit, without the need for health
professional involvement, in both clinical and nonclinical
settings. We are aware of no other studies that have investigated
using the internet for offering real-world cessation support to
pregnant smokers, although 2 previous studies have explored
this among nonpregnant smokers in the United States [32,33].
Our overall uptake rate (3.4%) was lower than that found among
all smokers offered a national Web-based cessation program
via commercial search-based and banner online adverts (6.8%)
[32]; however, it was similar to the uptake rate found when
banner adverts were used to promote Web-based cessation
support specifically to Latino smokers, another hard-to-reach
group (2.8%) [33]. Our average cost per initiation (£24.73)
compares favorably with costs reported to initiate general
smokers into real-world digital cessation support commercially
via the internet (mean $35) [32] and very favorably with costs
reported to initiate a hard-to-reach group via online banner
methods (mean $209.34) [33]. Facebook may be more
cost-effective than other banner-based methods for targeting
specific populations, given that adverts can be restricted to a
particular demographic [48].
Using an efficacy estimate of MiQuit from a previous RCT, we
estimated a cost per additional quitter of £735.86 to initiate
pregnant smokers into MiQuit through paid adverts, including
text message delivery costs but excluding development costs.
We did not include a formal cost-utility analysis here, and the
caveats discussed in our limitations must be noted, but this is
encouraging compared with costs reported for other smoking
cessation interventions that are effective and cost-effective in
pregnancy. For example, financial incentives are highly
cost-effective, with a cost per additional quitter of £1127 [49].
Of those who clicked to the MiQuit website, a much greater
percentage (11.6%) obtained the short code to initiate MiQuit
than subsequently texted it to do so (3.4%). Obtaining the short
code required a number of extra steps after clicking on an advert
and landing on the MiQuit website, suggesting that these women
were serious about taking up MiQuit. There may thus be
potential for increasing uptake substantially, at no extra
advertising cost, by ameliorating the drop-off between clicking
to accept the support and texting to initiate it. Having to text a
short code may be a barrier to initiating support for a number
of reasons, including lack of credit among pay-as-you-go phone
users, suspicion of hidden charges, and needing to act outside
of the website; enabling women to sign up anonymously without
the need to text a short code might increase uptake. Website
content, tone, and appearance are also potential targets; clearly
labeling the website as an NHS service might also reduce
women’s barriers to sending an initiation text.
A definitive evaluation is planned for MiQuit. If it is shown to
be effective, as our earlier trial suggests is likely [20], then an
assessment of its efficacy in an online setting may be warranted.
In this study, free-of-charge webpage links yielded relatively
few initiations but might have performed better if given greater
visibility. High initiation rates were found for women clicking
from these links, suggesting that they were well targeted despite
having lower reach than the commercial adverts, and pregnant
smokers may have been more likely to initiate MiQuit if reaching
it from a recognized health source. There may therefore be scope
for future work to promote MiQuit via such websites. Future
work could aim to minimize search engine–based advertising
costs by investigating which specific “smoking in pregnancy”
keyword phrases are associated with support initiations; this is
possible if support is initiated by a webpage click rather than
an external action such as texting a short code. Finally, it is
important to establish whether uptake of text-based cessation
support among pregnant smokers affects their uptake of
traditional cessation support or whether it attracts those who
would otherwise try to quit alone, if at all.
Conclusions
Commercial online advertising appears to be a promising method
for initiating pregnant smokers into text message–based
cessation support. Free and commercial adverts prompting
pregnant smokers to click to a sign-up website resulted in an
initiation rate of 3.4%. Search-based commercial advertising
was able to reach women earlier in pregnancy than interventions
delivered in clinical settings seem able to achieve, and those
who initiated support in this study had high readiness to quit.
Commercial online advertising to pregnant smokers is likely to
be cost-effective and can probably be made more so. Given that
pregnant smokers’ uptake of traditional support is low, it is
important to find successful strategies for offering them effective
alternatives.
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